• 제목/요약/키워드: Cancer diagnostics

검색결과 95건 처리시간 0.023초

위암의 시대적 변화 (Chronological Changes in the Clinical Features of Gastric Cancer)

  • 이천환;이선일;류근원;목영재
    • Journal of Gastric Cancer
    • /
    • 제1권3호
    • /
    • pp.161-167
    • /
    • 2001
  • Purpose: Although gastric carcinomas occur throughout the world and the incidence is on the decrease, they remain the most common type of carcinoma in Korea. Significant advancements in the diagnostics and the surgical treatment of gastric carcinomas have been achieved during the last three decades. The present retrospective study was undertaken to investigate the chronological changes in the clinical features, including clinicopathological findings, operative treatment, and prognosis of gastric carcinomas. Materials and Methods: A total of 1973 patients with a primary gastric adenocarcinoma who had been treated surgically during the period from 1983 to 1998 at the Department of Surgery, Korea University College of Medicine, were divided into two groups to evaluate chronological changes: 1007 patients had been treated during the period from 1983 to 1992 (early period) and 966 patients during the period from 1993 to 1998 (late period). Chronological changes in age, sex, ratio of early gastric cancer (EGC), and resectability were analyzed in all 1973 cases. For the 1755 resected cases, we also studied the chronological changes in the clinicopathological and treatment factors between the early-period (n=894) and the late-period (n=867) groups. Results: There were significant differences between the two periods with regard to age and ratio of EGC: EGC was more frequent in the late period. Univariate analysis of resected cases showed that gross type, tumor size, depth of invasion, UICC stage, and histological type were statistically significant. The analysis of the treatment factors revealed that total gastrectomies and extended lymphadenectomies were more frequent during the late period. The number of lymph nodes dissected was $26.0\pm12.7$ in the early period and $33.4\pm14.1$ in the late period (p<0.01). The 5-year survival rate in all cases was $51.4\%$ in the early period and $55.9\%$ in the late period. The stage-related survival rates (UICC 4th Ed., 1987) in the early vs. the late periods were $92.9\%\;vs.\;95.5\%$ in stage IA, $82.1\%\;vs.\;91.1\%$ in stage IB, $76.5\%\;vs.\;73.1\%$ in stage II, $46.5\%\;vs.\;52.1\%$ in stage IIIA, $14.5\%\;vs.\;33.6\%$ in stage IIIB, and $2.8\%\;vs.\;8.8\%$ in stage IV. There was a statistically significant difference in survival between stage IIIB and IV. Conclusion: These results suggest that the differences in the clinicopathological findings are related primarily to the increased number of early gastric cancer cases in the late period and that the improved survival noted during the late period for in stage IIIB and IV cancers might be related to extended surgery.

  • PDF

Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor

  • Bae, Jeong-Mo;Won, Jae-Kyung;Park, Sung-Hye
    • Journal of Korean Neurosurgical Society
    • /
    • 제61권3호
    • /
    • pp.376-385
    • /
    • 2018
  • Recent discoveries of brain tumor-related genes and fast advances in genomic testing technologies have led to the era of molecular diagnosis of brain tumor. Molecular profiling of brain tumor became the significant step in the diagnosis, the prediction of prognosis and the treatment of brain tumor. Because traditional molecular testing methods have limitations in time and cost for multiple gene tests, next-generation sequencing technologies are rapidly introduced into clinical practice. Targeted sequencing panels using these technologies have been developed for brain tumors. In this article, focused on pediatric brain tumor, key discoveries of brain tumor-related genes are reviewed and cancer panels used in the molecular profiling of brain tumor are discussed.

양성자 빔 암치료효과 개선을 위한 산화철 및 산화가돌리늄 나노입자 기반의 방사선증감제 합성 (A Synthesis of Iron Oxide Based and Gadolinium Oxide Based Radiosensitizer for the Therapeutic Enhancement of Proton Beam Cancer)

  • 강보선
    • 한국방사선학회논문지
    • /
    • 제8권6호
    • /
    • pp.325-332
    • /
    • 2014
  • 금속나노입자는 진단이나 치료를 포함한 의생명응용분야에 있어 매력적인 특징들을 갖고 있다. 양성자 빔 치료를 위한 방사선증감제로 사용하기 위해 가교덱스트란이 코팅된 산화철나노입자(SPIONs)와 실리카가 코팅된 산화가돌리늄나노입자(SPGONs)를 합성하였다. 덱스트란과 실리카는 각각 SPIONs와 SPGONs의 보호수단이다. 합성된 SPIONs와 SPGONs를 투과전자현미경(TEM)으로 분석한 결과 각각 평균 직경이 3~5 nm와 30~100 nm였다. 합성된 방사선 증감제의 효과를 평가하기 위해 세포생존곡선 측정과 Western blotting을 수행하였다. 측정된 세포생존곡선으로부터 계산된 90% 세포사멸 시 방사선증감비는 SPIONs와 SPGONs에 대하여 각각 1.23과 1.03이었다. Western blotting 결과 역시 Cytochrome C의 발현량이 SPIONs를 처리한 암세포에서 유의적으로 증가됨을 보였다.

Salivary biomarkers in oral squamous cell carcinoma

  • Nguyen, Truc Thi Hoang;Sodnom-Ish, Buyanbileg;Choi, Sung Weon;Jung, Hyo-Il;Cho, Jaewook;Hwang, Inseong;Kim, Soung Min
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제46권5호
    • /
    • pp.301-312
    • /
    • 2020
  • In disease diagnostics and health surveillance, the use of saliva has potential because its collection is convenient and noninvasive. Over the past two decades, the development of salivary utilization for the early detection of cancer, especially oral cavity and oropharynx cancer has gained the interest of the researcher and clinician. Until recently, the oral cavity and oropharynx cancers are still having a five-year survival rate of 62%, one of the lowest in all major human cancers. More than 90% of oral cancers are oral squamous cell carcinoma (OSCC). Despite the ease of accessing the oral cavity in clinical examination, most OSCC lesions are not diagnosed in the early stage, which is suggested to be the main cause of the low survival rate. Many studies have been performed and reported more than 100 potential saliva biomarkers for OSCC. However, there are still obstacles in figuring out the reliable OSCC salivary biomarkers and the clinical application of the early diagnosis protocol. The current review article discusses the emerging issues and is hoped to raise awareness of this topic in both researchers and clinicians. We also suggested the potential salivary biomarkers that are reliable, specific, and sensitive for the early detection of OSCC.

Meta-analysis of Association Studies of CYP1A1 Genetic Polymorphisms with Digestive Tract Cancers Susceptibility in Chinese

  • Liu, Chang;Jiang, Zheng;Deng, Qian-xi;Zhao, Ya-nan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권11호
    • /
    • pp.4689-4695
    • /
    • 2014
  • Background: A great number of studies have shown that cytochrome P450 1A1 (CYP1A1) genetic polymorphisms, CYP1A1 Msp I and CYP1A1 Ile/Val, might be risk factors for digestive tract cancers, including esophageal cancer (EC), gastric cancer (GC), hepatic carcinoma (HC), as well as colorectal cancer (CC), but the results are controversial. In this study, a meta-analysis of this literature aimed to clarify associations of CYP1A1 genetic polymorphisms with digestive tract cancers susceptibility in Chinese populations. Materials and Methods: Eligible case-control studies published until December 2013 were retrieved by systematic literature searches from PubMed, Embase, CBM, CNKI and other Chinese databases by two investigators independently. The associated literature was acquired through deliberate search and selection based on established inclusion criteria. Fixed-effects or random-effects models were used to estimate odds ratios (ORs and 95%CIs). The meta-analysis was conducted using Review Manager 5.2 and Stata 12.0 softwares with stability evaluated by both stratified and sensitivity analyses. Moreover, sensitivity analysis and publication bias diagnostics confirmed the reliability and stability. Results: Eighteen case-control studies with 1,747 cases and 2,923 controls were selected for CYP1A1 MspI polymorphisms, and twenty case-control studies with 3, 790 cases and 4, 907 controls for the CYP1A1 Ile/Val polymorphisms. Correlation associations between CYP1A1 Ile/Val polymorphisms and digestive tract cancers susceptibility were observed in four genetic models in the meta-analysis (GG vs AA:OR= 2.03, 95%CI =1.52- 2.72; AG vs AA: OR=1.26, 95%CI =1.07-1.48; [GG+AG vs AA] :OR =1.42, 95%CI=1.20-1.68, [GG vs AA+AG]:OR=1.80, 95%CI =1.40-2.31). There was no association between CYP1A1 Msp I polymorphisms and digestive tract cancers risk. Subgroup analysis for tumor type showed a significant association of CYP1A1 Ile/Val genetic polymorphisms with EC in China. However, available data collected by the study failed to reveal remarkable associations of GC or HC with CYP1A1 Ile/Val genetic polymorphisms and EC, GC or CC with CYP1A1 MspI genetic polymorphisms. Conclusions: Our results indicated that CYP1A1 Ile/Val genetic polymorphisms, but not CYP1A1 Msp I polymorphisms, are associated with an increased digestive tract cancers risk in Chinese populations. Additional well-designed studies, with larger sample size, focusing on different ethnicities and cancer types are now warranted to validate this finding.

유방암 환자의 Positron Emission Mammography에서의 유용성에 관한 연구 (A Study on Availability about Positron Emission Mammography of Breast Cancer)

  • 김승정;김재일;김진의;김현주
    • 핵의학기술
    • /
    • 제14권2호
    • /
    • pp.60-64
    • /
    • 2010
  • 유방암의 진단을 위해 단순유방촬영, 유방초음파검사, $^{18}F$-FDG PET 검사가 대부분 함께 이루어지고 있다. 그러나 이들 검사의 단점을 보완하고자 보다 더 높은 예민도, 특이도, 정확도를 가진 PEM이 도입되었다. 본 연구에서는 유방암의 진단을 향상시키는 PEM의 유용성을 알아보고자한다. 2010년 1월부터 3월까지 유방외과에서 유방암 진단을 받은 환자 100명을 대상으로 PEM 검사를 시행하였다. 장비는 Naviscan사의 PEM Flex Solo II scanner를 사용하였다. PEM 영상결과와 수술 후 병리결과를 비교하여 PEM 검사의 예민도, 특이도, 정확도를 평가하였다. 환자 100명에서 PEM 영상과 수술 후 병리결과를 통해 알아본 결과로 진양성은 89, 위양성은 9, 위음성은 7, 진음성은 87이었다. PEM 검사의 예민도, 특이도, 정확도는 각각 92.7%, 90.6%, 91.7%로 나타났다. 단순유방촬영에서 예민도 86.2%, 특이도 64.5%로 보고되어 있고 유방초음파검사에서 예민도 87.9%, 특이도 76.7%로 알려져 있다. 본 연구에서 PEM은 예민도 92.7%, 특이도 90.6%로 다른 검사보다 높게 나타났다. 이로써 PEM은 유방암을 진단하고 수술하기 전의 더 나은 수술 계획에 사용될 수 있으며 국소 부위 재발의 발견에 도움이 될 것으로 사료된다.

  • PDF

Clinical Evaluation of Human Papillomavirus DNA Genotyping Assay to Diagnose Women Cervical Cancer

  • Kim, Sung-Hyun;Lee, Dong-Sup;Kim, Yeun;Kim, Gee-Hyuk;Park, Sang-Jung;Choi, Yeon-Im;Kim, Tae-Ue;Park, Kwang-Hwa;Lee, Hye-Young
    • 대한의생명과학회지
    • /
    • 제18권2호
    • /
    • pp.123-130
    • /
    • 2012
  • In this study, we evaluated the human papillomavirus (HPV) genotyping test called MolecuTech REBA HPV-$ID^{(R)}$ (YD Diagnostics, Seoul, Korea) for 704 women who also had cervical cytological evaluations by Thin Prep. The infection rate of high-risk HPV genotypes was 56.6% in patients with normal cytology, 59.8% in those with benign, low-grade squamous intraepithelial lesions, 51.4% in those with atypical squamous cells of uncertain significance, 92.3% in those with high-grade squamous intraepithelial lesions, and 94.1% in those with squamous cell carcinoma or adenocarcinoma. HPV 16 was the most common genotype detected in any lesion, followed by HPV 53, 58, 33, 52, 45, 31, and 35, in order. The HPV DNA test with PCR-REBA is a very highly sensitive, but less specific, method. The infection rates and HPV genotype distribution of non-Korean people versus people from South Korea showed regional differences.

Ginsenoside Rg1 Induces Apoptosis through Inhibition of the EpoR-Mediated JAK2/STAT5 Signalling Pathway in the TF-1/Epo Human Leukemia Cell Line

  • Li, Jing;Wei, Qiang;Zuo, Guo-Wei;Xia, Jing;You, Zhi-Mei;Li, Chun-Li;Chen, Di-Long
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권6호
    • /
    • pp.2453-2459
    • /
    • 2014
  • Ginsenoside Rg1 is one effective anticancer and antioxidant constituent of total saponins of Panax ginseng (TSPG), which has been shown to have various pharmacological effects. Our previous study demonstrated that Rg1 had anti-tumor activity in K562 leukemia cells. The aim of this study was designed to investigate whether Rg1 could induce apoptosis in TF-1/Epo cells and further to explore the underlying molecular mechanisms. Here we found that Rg1 could inhibit TF-1/Epo cell proliferation and induce cell apoptosis in vitro in a concentration and time dependent manner. It also suppressed the expression of EpoR on the surface membrane and inhibited JAK2/STAT5 pathway activity. Rg1 induced up-regulation of Bax, cleaved caspase-3 and C-PAPR protein and down-regulation of Bcl-2 and AG490, a JAK2 specific inhibitor, could enhance the effects of Rg1. Our studies showed that EpoR-mediated JAK2/STAT5 signaling played a key role in Rg1-induced apoptosis in TF-1/Epo cells. These results may provide new insights of Rg1 protective roles in the prevention a nd treatment of leukemia.

임상 생체지표를 이용한 오장생체나이 추정 모델 (Models for Predicting Five Jang Biological Ages with Clinical Biomarkers)

  • 김태희;김석;배철영;강영곤;조경희;권수경;박미화
    • 대한한의진단학회지
    • /
    • 제15권2호
    • /
    • pp.175-190
    • /
    • 2011
  • Objectives: Even though there has been no consensus on the concept of viscera organ between the oriental and western medicine, we tried to investigate the correlation between clinical biomarkers of five Jang and chronological age and develop the models for predicting five Jang biological ages by statistical analysis. Methods: We obtained data from about 120,000 subjects who visited health promotion centers for health promotion and disease prevention from January 2004 to June 2009. Participants were included if they were over 20 years old, and excluded if reported to have cardiovascular disease or other serious medical illness such as cancer, malignant hypertension, uncontrolled diabetes, cardiopulmonary insufficiency, liver disease, pancreatic disease or renal disease. Among the clinical biomarkers obtained, we selected the biomarkers which were associated with the function of 5 Jang in previous studies, or showed statistically significant correlation with age. Multiple regression models were used for building prediction models of biological age after adjusting for potential confounders for men and women, respectively. Pearson correlation coefficient was calculated to examine the linear relationship between age and various biomarkers, and multiple regression analysis was used for building the prediction models of five Jang biological ages for men and women, respectively. All statistical data analysis was performed by using SPSS Version 12.0 software and statistical significance was obtained if p<0.05. Results: For males, the best models were developed using 12, 2, 8, 3, and 4 biomarkers for predicting biological ages of heart, lung, liver, pancreas, and kidney, respectively (R2 = 0.57, 0.43, 0.11, 0.24, and 0.93, respectively). Similar to males, for the females, 10, 2, 8, 3, and 4 biomarkers were selected as the models respectively (R2 = 0.76, 0.44, 0.14, 0.38, and 0.89, respectively). Conclusions: As we have developed for the first time the models for predicting five Jang biological ages with common clinical biomarkers, it is expected that these models may be used as clinical supplementary tools in the evaluation of aging status and functional decline of five Jang according to age in health promotion centers and private clinics. At the same time, it is considered that the use as objective tools to evaluate aging status and functional decline of each Jang.

Collagen 유도의 사람 혈소판에서 인산화 단백질 조절을 통한 hydroxygenkwanin의 혈소판 응집억제 효과 (Inhibitory effects of hydroxygenkwanin on platelets aggregation via regulation of phosphoproteins in collagen-induced human platelets)

  • 박창은;이동하
    • Journal of Applied Biological Chemistry
    • /
    • 제66권
    • /
    • pp.122-127
    • /
    • 2023
  • 심혈관 질환(CVD)은 전 세계적으로 주요 사망 원인으로써 갈수록 증가하는 추세이며, 혈관 손상이 발생하였을 때, 혈전이 과도하게 형성되는 것이 그 원인인 중 하나이다. 근래에 혈소판 억제를 통한 항혈전 물질에 대한 관심이 커지고 있으며 천연 생물활성 화합물을 사용함으로써 부작용을 줄이려는 노력이 이루어지고 있다. Flavonoid 중 하나로 알려진 hydroxygenkwanin(HGK)은 팥꽃나무(Daphne genkwa)에서 정제되는 물질로서 항균, 항염증 및 항암 효과가 있다고 알려져 있으며, 혈전증을 예방하는 조직 인자의 억제제 역할을 한다고 보고되었지만 항혈소판 효과와 그 작용기전에 대해서는 거의 알려지지 않았다. 본 연구를 통해 HGK가 collagen 유도의 사람 혈소판 응집에 미치는지 확인하였고, 그 작용 기전을 확인하였다. HGK은 혈소판 신호 전달 과정에서 PI3K/AKT 및 MAPK의 인산화를 억제하였고, ATP 및 serotonin 등의 혈소판 내 과립 분비를 감소하였다. . 또한, HGK는 cPLA2의 인산화를 억제하며 응집 촉진물질인 TXA2 생성을 강하게 저해하였다. 결과적으로 응집 유도 물질인 collagen가 유도한 혈소판 응집을 86.36 µM의 IC50로 강하게 억제하였다. 그러므로, 본 연구를 통해 HGK가 혈관 손상을 통해 일어나는 사람 혈소판의 활성화 및 응집을 억제하는 항혈전 물질로 가치가 있음을 분명히 하였다.